Merck presented Data on Tepotinib for NSCLC at ESMO Asia 2019

Drug Discovery |  News | 0 Comment | 25 Nov, 2019

Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tep...Read more

BeiGene receives its first FDA approval

Drug Discovery |  News | 0 Comment | 18 Nov, 2019

BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...Read more

Yuhan Pharmaceuticals partners with Cyclica

Drug Discovery |  News | 0 Comment | 13 Nov, 2019

South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology c...Read more

China approves Alzheimer's drug

Drug Discovery |  News | 0 Comment | 11 Nov, 2019

The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing o...Read more

Samsung Biologics collaborates with Ichnos Sciences in derma space

Drug Discovery |  News | 0 Comment | 06 Nov, 2019

South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Scie...Read more

EU approves BAVENCIO® (avelumab) Plus Axitinib to treat RCC

Drug Discovery |  News | 0 Comment | 29 Oct, 2019

Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelu...Read more

Biogen plans regulatory filing for Aducanumab for Alzheimer's

Drug Discovery |  News | 0 Comment | 23 Oct, 2019

Biogen and Eisai, Co., Ltd. (Tokyo, Japan) has announced that, after consulting with the U.S. Food and Drug Administrati...Read more

Takeda acquires license for celiac disease therapy

Drug Discovery |  News | 0 Comment | 22 Oct, 2019

Japanese firm Takeda Pharmaceutical Company  and US based COUR Pharmaceutical Development Company, Inc. have announ...Read more

NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

Drug Discovery |  News | 0 Comment | 21 Oct, 2019

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products,...Read more

Trastuzumab deruxtecan gets FDA priority review to treat metastatic breast cancer

Drug Discovery |  News | 0 Comment | 18 Oct, 2019

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) have announced that the US Food and Drug Administration...Read more

Lilly's Migraine drug receives FDA approval

Drug Discovery |  News | 0 Comment | 14 Oct, 2019

Eli Lilly and Company  has announced that the U.S. Food and Drug Administration (FDA) has approved REYVOW...Read more

Gilead Sciences submits NDA to treat RA in Japan

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Gilead Sciences, Inc. has announced the New Drug Application (NDA) for filgotinib, an investigational, oral, select...Read more

Bayer and RIKEN establish partnership for novel drug discovery

Drug Discovery |  News | 0 Comment | 09 Oct, 2019

Bayer AG (Bayer), and RIKEN Innovation Co., Ltd. (RIKEN Innovation), have entered into a strategic collaboration agreeme...Read more

Novo Nordisk set to bring innovative treatment for type 2 diabetes

Drug Discovery |  News | 0 Comment | 23 Sep, 2019

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) ta...Read more

FDA approves combo drug to treat endometrial carcinoma

Drug Discovery |  News | 0 Comment | 19 Sep, 2019

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the...Read more

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab)

Drug Discovery |  News | 0 Comment | 18 Sep, 2019

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakt...Read more

FDA grants priority review for Merck’s Ebola Vaccine

Drug Discovery |  Influencers | 3 Comment | 17 Sep, 2019

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA)...Read more

Certara launches V8.2 of Phoenix PK/PD modeling & simulation software for drugs

Drug Discovery |  News | 0 Comment | 15 Sep, 2019

Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the laun...Read more